CLK4: CDC Like Kinase 4
A member of the CDC2-like kinase family involved in alternative splicing regulation and cell cycle control.
Gene Information Card
| Symbol | CLK4 |
|---|---|
| Full Name | CDC like kinase 4 |
| Gene Type | protein-coding |
| Chromosomal Location | 5q35.3 |
| NCBI Gene ID | 57396 ncbi.nlm.nih.gov/gene/57396 |
| Ensembl ID | ENSG00000113240 |
| UniProt ID | Q9HAZ1 |
| OMIM ID | 610990 |
| HGNC ID | 13515 |
| Aliases | CLK4, CDC-like kinase 4, MGC138207 |
Description
CLK4 encodes a member of the CDC2-like kinase family. These kinases phosphorylate serine/arginine-rich (SR) proteins, regulating their nuclear localization and activity in pre-mRNA splicing. CLK4 is involved in cell cycle progression, apoptosis, and differentiation. Alternative splicing of CLK4 itself produces multiple transcript variants.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Cancer (various) | CLK4 overexpression alters splicing of oncogenes and tumor suppressors, promoting proliferation. | COSMIC; PMID: 25691885 |
| Neurodevelopmental disorders | CLK4 variants may disrupt splicing of neuronal genes, but evidence is limited. | ClinVar; PMID: 31073040 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Testis | 12.5 | Medium |
| Brain | 8.2 | Medium |
| Lung | 6.1 | Low |
| Liver | 3.4 | Low |
| Heart | 2.8 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK293 | 15.3 | High expression |
| HeLa | 9.7 | Moderate expression |
| K562 | 5.1 | Low expression |
| HepG2 | 4.0 | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1045C>T (p.Arg349Trp) | Missense | <0.01% | Unknown; rare variant in ClinVar |
| c.1234G>A (p.Glu412Lys) | Missense | <0.01% | Unknown; rare variant in ClinVar |
| Amplification | Copy number gain | ~2% in breast cancer | Potential gain-of-function; COSMIC |
Mutation functional classification
Loss of Function (LOF)
No confirmed loss-of-function mutations reported.
Gain of Function (GOF)
Amplification and overexpression observed in some cancers may confer gain-of-function.
Dominant Negative (DN)
No dominant-negative mutations described.
View complete mutation data:
Gene Ontology (GO)
| • protein kinase activity (GO:0004672) | • ATP binding (GO:0005524) |
| • mRNA processing (GO:0006397) | • RNA splicing (GO:0008380) |
| • nucleus (GO:0005634) | • protein phosphorylation (GO:0006468) |
Pathways
• Alternative splicing (Reactome: R-HSA-72172)
• SRP-dependent cotranslational protein targeting to membrane (Reactome: R-HSA-1799339)
Protein Summary
CLK4 is a dual-specificity kinase that phosphorylates serine and threonine residues on SR proteins, regulating their activity in spliceosome assembly. It contains a catalytic kinase domain and an N-terminal region involved in nuclear localization. The protein is 481 amino acids long with a molecular weight of ~54 kDa.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CLK4 Knockout HAP1 Cell Line | EDC08228 | Human | 57396 | Details Get a Quote |
| Clk4 Knockout MC3T3-E1 Cell Line | EDJ-KZ164 | Mouse | 12750 | Details Get a Quote |
| CLK4 Knockout HeLa Cell Line | EDJ-KQ25276 | Human | 57396 | Details Get a Quote |
| CLK4 Knockout HCT 116 Cell Line | EDJ-KQ25275 | Human | 57396 | Details Get a Quote |
| CLK4 Knockout A-549 Cell Line | EDJ-KQ25274 | Human | 57396 | Details Get a Quote |
| CLK4 Knockout HEK293 Cell Line | EDJ-KQ3490 | Human | 57396 | Details Get a Quote |